The escalation in hip-related problems in the global population is predicted to enhance the hip implants market. The healthcare reports are made by Market Research Future, which includes market options for expansion. Hip Implants Market is expected to hold a value of USD 9,300 Million by 2025 at a CAGR of 4.1%.

The incidence of bone-related ailments, such as osteoarthritis is boosting the progress of the hip implants market share in the impending period. The amplified success rate of hip replacement surgeries is foreseen to exert an optimistic effect on the hip implants market companies in the forecast period.

Segmental Analysis 

The segmental study of the hip implants market has been conducted based on the product, material, region and end-user. On the basis of product, the hip implants market has been segmented into partial hip replacement implants and total hip replacement implants. Based on the regions, the hip implants market is segmented into the Americas, Europe, Asia Pacific, Africa and the Middle East. On the basis of end-users, the hip implants market is segmented into orthopaedic clinics, ambulatory surgical centres, hospitals, and others. On the basis of material, the hip implants market has been segmented into metal-on-metal, ceramic-on-metal, metal-on-polyethylene, ceramic-on-polyethylene, and ceramic-on-ceramic.

Detailed Regional Analysis 

The regional appraisal of the hip implants market includes regions such as the Americas, Europe, Asia Pacific, Africa and the Middle East. The Americas regional hip implants market is foreseen to lead the global market in the appraisal period. In national markets such as Canada and the US, the increasing frequency of hip-related illnesses and the incidence of maximum companies are backing the development of the hip implants market in this region. The speedy modernization in technology joined with great research development (RD) spending in the area of hip replacement surgery, is projected to lift the progress of the hip implants market in the European regional market. The Asia Pacific regional hip implants market is predicted to be the swiftest escalating region in the global market. The APAC regional market is also seeing an intensification in the elderly population, which will benefit the expansion of the market in the long term. The frequency of osteoarthritis and joint-related ailments are elevated in the geriatric population, and this aspect is estimated to bolster the hip implants market. The Middle Eastern and African regional market is estimated to lag owing to restricted healthcare infrastructure and restricted exposure to technological improvements.

Competitive Analysis

The unprecedented socioeconomic challenges are estimated to have a noticeable effect on the global market in the duration of the forecast period. The incorporation of digitalized processes in businesses is predicted to spur the market in the impending period. The organizations are likely to improve their response time and reaction to crisis considerably in the upcoming years regarding the current situation created by the global pandemic. The stimulating effect of analytics to business value is estimated to encourage innovation and more strategically plans in the forthcoming period. The impact of automation is estimated to trickle to virtually every area of business operations and fostering the development of the global market in the forecast years. The market is estimated to exhibit a resurgent phase of development in the impending period. The market is also foreseen to take significant strides to achieve major digital investments in areas such as AI engineering and distributed cloud. The gradual growth in the bottom-line results is estimated to be conducive to the market players plans’ for the future.

The illustrious companies in the hip implants market are DJO Global, Inc. (US), Exactech, Inc. (US), OMNILife science, Inc. (US), Stryker Corporation (UK), Zimmer Biomet Holdings, Inc. (US), Smith Nephew PLC (UK), MicroPort Scientific Corporation (China), Corin (UK), B. Braun Melsungen AG (Germany), and Aesculap Implant Systems, LLC (US).